nach oben

Reactions Weekly

Erschienen in:

01.03.2019 | Case report

Rituximab

Allergic reaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a study of 28 patients, a patient [age and sex not stated] was described, who developed an allergic reaction during treatment with rituximab. The patient, who had thrombotic thrombocytopenic purpura (TTP) was admitted due to its exacerbation. During the admission, the patient was treated with unspecified steroids and plasmapheresis. The patient started receiving treatment with rituximab [dosage and route not stated]. During the second cycle, the patient developed an allergic reaction [exact time to reaction onset not stated]. Consequently, the rituximab therapy was stopped [outcome not stated]. …

Goshua G, et al. Cost effectiveness of rituximab as adjunctive therapy in reducing apheresis procedures and hospital length of stay in relapsed thrombotic thrombocytopenic purpura. Blood 132 (Suppl. 1): (plus poster) abstr. 3814, 3 Dec 2018. Available from: URL: http://doi.org/10.1182/blood-2018-99-113621 [abstract] - USA

Titel: Rituximab
Allergic reaction: case report
Publikationsdatum: 01.03.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-59136-1

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Rituximab

Allergic reaction: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Loperamide overdose

Albendazole

Pembrolizumab

Allopurinol

Isoniazid/leflunomide/tocilizumab

Infliximab